Applying human factors to medical devices

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding usability engineering for medical device manufacturers and developers of drug-device combination products. This regulatory framework applies to all device classes and UK-approved bodies, focusing on the design of future products and updates to existing user interfaces. The guidance establishes that usability engineering is an iterative process involving design, testing, and validation stages. Manufacturers are required to integrate this process into their risk management strategies to identify, assess, and mitigate potential hazards to patients and users. A key aspect of the guidance is the focus on the post-market phase, where evidence from clinical practice must be used to inform design improvements. While this document is not an inspection report for a specific company or date, it outlines the mandatory actions for all manufacturers: they must analyze incidents to identify learning opportunities and implement corrective actions that enhance device safety. By prioritizing user-centric design and continuous improvement, the MHRA seeks to minimize the risk of use-related errors and ensure that medical devices remain safe and effective throughout their entire lifecycle.